An investigation of the chick chorioallantoic membrane as an alternative model to various biological tissues for permeation studies

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 10, 2011, Pages 1283-1289

  Tay, Stephanie Li Mei ^a   Heng, Paul Wan Sia ^a   Chan, Lai Wah ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

buccal mucosa; chick chorioallantoic membrane; permeation

Indexed keywords

NICOTINE;

ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; CHEEK MUCOSA; CHICK; CHORIOALLANTOIS; CONTROLLED STUDY; DIFFUSION; DRUG TRANSPORT; FREEZING; FROZEN SECTION; IN VITRO STUDY; MEMBRANE MODEL; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; NONHUMAN; RETINA; SNAKE; SWINE;

ABSORPTION; ANIMALS; BIOLOGICAL TRANSPORT; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; MODELS, BIOLOGICAL; MOUTH MUCOSA; NICOTINE; RETINA; SKIN; SKIN ABSORPTION; SNAKES; SWINE;

EID: 80052588671     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01338.x     Document Type: Article

References (38)

1. Romanoff AL,. The Avian Embryo; Structural and Functional Development. New York: The Macmillan Company, 1960.
2. Fuchs A, Lindenbaum ES,. The two- and three-dimensional structure of the microcirculation of the chick chorioallantoic membrane. Acta Anat (Basel) 1988; 131: 271-275. (Pubitemid 18098141)
3. Forough R, et al,. Cell-based and direct gene transfer-induced angiogenesis via a secreted chimeric fibroblast growth factor-1 (sp-FGF-1) in the chick chorioallantoic membrane (CAM). Angiogenesis 2003; 6: 47-54. (Pubitemid 37305339)
4. Richardson M, et al,. Inhibition by doxycycline of angiogenesis in the chicken chorioallantoic membrane (CAM). Cancer Chemother Pharmacol 2005; 56: 1-9. (Pubitemid 41201749)
5. Dunn LK, et al,. Chick chorioallantoic membrane as an in vivo model to study vasoreactivity: characterization of development-dependent hyperemia induced by epoxyeicosatrienoic acids (EETs). Anat Rec A Discov Mol Cell Evol Biol 2005; 285: 771-780. (Pubitemid 41098873)
6. Daston GP, McNamee P,. Alternatives to Toxicity Testing in Animals: Challenges and Opportunities. [Environmental Health Perspectives-Online monthly journal of peer-reviewed research] 2005 Nov 2005 [cited September 2005].
7. Vinardell MP, Garcia L,. The quantitative chorioallantoic membrane test using trypan blue stain to predict the eye irritancy of liquid scintillation cocktails. Toxicol In Vitro 2000; 14: 551-555.
8. Kunzi-Rapp K, et al,. Characterization of the chick chorioallantoic membrane model as a short-term in vivo system for human skin. Arch Dermatol Res 1999; 291: 290-295. (Pubitemid 29225055)
9. Debbasch C, et al,. Eye irritation of low-irritant cosmetic formulations: correlation of in vitro results with clinical data and product composition. Food Chem Toxicol 2005; 43: 155-165. (Pubitemid 39575743)
10. Cobb GP, et al,. Using chorioallantoic membranes for non-lethal assessment of persistent organic pollutant exposure and effect in oviparous wildlife. Ecotoxicology 2003; 12: 31-45. (Pubitemid 36398819)
11. Zorin S, et al,. In vitro test of nicotine's permeability through human skin. Risk evaluation and safety aspects. Ann Occup Hyg 1999; 43: 405-413. (Pubitemid 29414870)
12. Baker ND, et al,. The percutaneous absorption of m-azidopyrimethamine: a soft antifolate for topical use. Int J Pharm 1990; 65: 115-125.
13. Pongjanyakul T, et al,. Shed king cobra and cobra skins as model membranes for in-vitro nicotine permeation studies. J Pharm Pharmacol 2002; 54: 1345-1350. (Pubitemid 35174179)
14. Shargel LW-P, et al,., eds. Applied Biopharmaceutics and Pharmacokinetics, 5th edn. USA: The McGraw-Hill Companies, 2005.
15. Shumko JZ, et al,. Vascular histodifferentiation in the chick chorioallantoic membrane: a morphometric study. Anat Rec 1988; 220: 179-189. (Pubitemid 18063584)
16. Yazdanian M,. The effect of freezing on cattle skin permeability. Int J Pharmaceutics 1994; 103: 93-96. (Pubitemid 24035820)
17. Van Eyk AD, Van der Biijl P,. Comparative permeability of fresh and frozen/thawed porcine buccal mucosa towards various chemical markers. SADJ 2006; 61: 200-203.
18. Ahlstrom LA, et al,. The effects of freezing skin on transdermal drug penetration kinetics. J Vet Pharmacol Ther 2007; 30: 456-463. (Pubitemid 47366602)
19. Babu RJ, et al,. The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide. J Control Release 2003; 86: 49-57. (Pubitemid 35461973)
20. Kemppainen BW, et al,. Effects of skin storage-conditions and concentration of applied dose on [H-3] T-2 toxin penetration through excised human and monkey skin. Food Chem Toxicol 1986; 24: 221-227. (Pubitemid 16128941)
21. Swarbrick J, et al,. Drug permeation through human-skin. 1. Effect of storage-conditions of skin. J Invest Dermatol 1982; 78: 63-66. (Pubitemid 12207158)
22. Schafer AT, Kaufmann JD,. What happens in freezing bodies? Experimental study of histological tissue change caused by freezing injuries. Forensic Sci Int 1999; 102: 149-158. (Pubitemid 29296842)
23. Barbero AM, Frasch HF,. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol In Vitro 2009; 23: 1-13.
24. Lin SY, et al,. Comparisons of different animal skins with human skin in drug percutaneous penetration studies. Methods Find Exp Clin Pharmacol 1992; 14: 645-654.
25. Maibach HI, Bronaugh RL,. Topical Absorption of Dermatological Products. New York: Marcel Dekker, 2002.
26. Berner B, et al,. A transdermal nicotine system: feasibility studies. J Control Release 1992; 20: 13-19.
27. Zwadlo-Klarwasser G, et al,. The chorioallantoic membrane of the chick embryo as a simple model for the study of the angiogenic and inflammatory response to biomaterials. J Mater Sci Mater Med 2001; 12: 195-199. (Pubitemid 32207074)
28. Dupuis D, et al,. In vivo relationship between horny layer reservoir effect and percutaneous absorption in human and rat. J Invest Dermatol 1984; 82: 353-356. (Pubitemid 14131460)
29. Godin B, Touitou E,. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 2007; 59: 1152-1161. (Pubitemid 47615204)
30. Takahashi K, Rytting JH,. Novel approach to improve permeation of ondansetron across shed snake skin as a model membrane. J Pharm Pharmacol 2001; 53: 789-794. (Pubitemid 32529721)
31. Itoh T, et al,. Use of shed snake skin as a model membrane for invitro percutaneous penetration studies-comparison with human skin. Pharm Res 1990; 7: 1042-1047. (Pubitemid 20366732)
32. Cunhavaz JG,. Blood-retinal barriers in health and disease. Trans Ophthalmol Soc U K 1980; 100: 337-340.
33. Leng T, et al,. The chick chorioallantoic membrane as a model tissue for surgical retinal research and simulation. Retina 2004; 24: 427-434. (Pubitemid 38780473)
34. Duvvuri S, et al,. Drug delivery to the retina: challenges and opportunities. Expert Opin Biol Ther 2003; 3: 45-56. (Pubitemid 36193650)
35. Tanojo H, et al,. In vivo human skin permeability enhancement by oleic acid: a laser Doppler velocimetry study. J Control Release 1999; 58: 97-104. (Pubitemid 29371817)
36. Obradovic T, Hidalgo IJ,. In vitro models for investigations of buccal drug permeation and metabolism. In:, Ehrhardt C, Kim K, eds. Drug Absorption Studies: In Situ, In Vitro and In Silico Models. New York: Springer, 2008: 167-181.
37. Tavakoli-Saberi MR, Audus KL,. Cultured buccal epithelium: an in vitro model derived from the hamster pouch for studying drug transport and metabolism. Pharm Res 1989; 6: 160-166.
38. Nicolazzo JA, et al,. Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Control Release 2005; 105: 240-248. (Pubitemid 40941989)